If you need more predictable medication outcomes in Eden Prairie, pharmacogenetic testing provides genetic data that helps your provider select drugs and doses better aligned with how your body actually metabolizes them. Rather than cycling through medications based on general population averages, PGx testing reveals whether specific enzymes in your body process certain drugs too quickly, too slowly, or at a rate that puts standard doses outside therapeutic range.

True North Medical Care uses pharmacogenetic testing as one tool within a broader clinical evaluation—not as a standalone prescription generator. The test involves a simple cheek swab analyzed for genetic variants affecting drug metabolism pathways relevant to antidepressants, pain medications, cardiovascular drugs, and other commonly prescribed classes. When results show you're a rapid metabolizer of a specific medication class, your provider can factor that into dosing rather than discovering the pattern through failed trials and patient frustration.

This approach matters most for Eden Prairie patients who've experienced side effects that seemed disproportionate to the dose, received multiple prescription changes for the same condition, or want additional information before committing to a new long-term medication.

Testing begins with a clinical consultation that determines whether PGx analysis is appropriate for your situation and which medication classes are most relevant to your current treatment goals. Not every patient benefits equally from pharmacogenetic testing, but when it's clinically applicable, the process is straightforward and non-invasive.

• If you've tried multiple antidepressants without lasting benefit, PGx results may clarify whether metabolism patterns contribute to the pattern of poor response
• When a new medication is being considered for a chronic condition, genetic data supports dosing that better suits your individual metabolic profile
• If you've experienced unexplained side effects at standard doses, metabolizer status can help clarify whether clearance rate is a contributing factor
• When managing multiple medications, PGx analysis can identify overlapping metabolic pathways that increase interaction risk
• For Eden Prairie patients beginning treatment for depression, anxiety, or cardiovascular conditions, results provide a starting point that may reduce prolonged trial periods

Contact us to discuss whether pharmacogenetic testing fits your clinical situation and how results are integrated into treatment decisions in Eden Prairie.

A PGx evaluation at True North Medical Care involves more than returning a lab report. Results are interpreted in the context of your full medical picture, with guidance that reflects your diagnosed conditions, current medications, and treatment history.

• Cheek swab or blood draw collected and sent to a laboratory analyzing genetic variants in key drug-metabolizing enzyme pathways
• Results reviewed by your provider alongside current medications to identify any pharmacogenomic considerations relevant to your care
• Clinical interpretation that explains what your metabolizer status means for the specific drug classes applicable to your treatment
• Treatment guidance based on combined PGx data, organ function, medical history, and existing prescriptions—not genetics alone
• Follow-up monitoring in Eden Prairie to assess how medication adjustments informed by genetic insights are working over time

Pharmacogenetic testing is most effective when incorporated into ongoing care where providers track treatment response and adjust as needed. Schedule a consultation to explore whether PGx testing supports your current or upcoming treatment plan.